Hong Chen

Company: Novo Nordisk

Job title: Director - Search & Evaluation

Seminars:

Panel Discussion: Discussing the Future of GLP-1s: Applications Beyond Obesity & Future Challenges 3:00 pm - 3:30 pm

Advancing the reach of GLP-1-based treatments past obesity and metabolism, into neurology and beyond Exploring the maintenance of scientific validity in future studies of GLP-1s as the percentage of the population taking these therapies increases Considering the impact of generic forms of GLP-1s on the current commercial landscape of the incretin fieldRead more

day: Day Two

Panel Discussion 4:30 pm - 5:00 pm

Hear from large pharma, investors, and experienced biotech leaders as they dive into the scientific and commercial factors of a setting up a successful partnership to develop GLP-1 based therapeutics for indications in obesity and beyond Uncover the key end-to-end key milestones that are evaluated when deciding on investment and partnership opportunities Ask your questions…Read more

day: Day One